An in-silico revolution in biotechnology

Enough experimenting! The KIT spinoff GoSilico enables the biopharmaceuticals branch to introduce the computer-supported development of manufacturing processes for new agents.

The way from the discovery of a promising agent to its authorisation is tedious. It involves countless experiments that not only cause high costs but also require a considerable amount of perseverance. “It can take up to ten years for a drug to enter the market,” says Dr Thiemo Huuk. This is a shortcoming that he tends to address together with his co-founders Prof Dr Jürgen Hubbuch, Dr Teresa Beck and Dr Tobias Hahn.

The founders of GoSilico (left to right): Dr. Thiemo Huuk, Dr. Tobias Hahn and Dr. Teresa Beck (Source: Foto Fabry)

The founders of GoSilico (left to right): Dr. Thiemo Huuk, Dr. Tobias Hahn and Dr. Teresa Beck (Source: Foto Fabry)

Continue reading